DPF2
Basic information
Region (hg38): 11:65333843-65354262
Previous symbols: [ "REQ" ]
Links
Phenotypes
GenCC
Source:
- Coffin-Siris syndrome 7 (Moderate), mode of inheritance: AD
- Coffin-Siris syndrome 7 (Strong), mode of inheritance: AD
- Coffin-Siris syndrome (Supportive), mode of inheritance: AD
- Coffin-Siris syndrome 7 (Strong), mode of inheritance: AD
- Coffin-Siris syndrome (Definitive), mode of inheritance: AD
- Coffin-Siris syndrome 7 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Coffin-Siris syndrome 7 | AD | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Craniofacial; Cardiovascular; Musculoskeletal; Neurologic | 29429572 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (178 variants)
- Inborn_genetic_diseases (33 variants)
- Coffin-Siris_syndrome_7 (26 variants)
- DPF2-related_disorder (14 variants)
- Autism_spectrum_disorder (1 variants)
- Developmental_disorder (1 variants)
- Coffin-Siris_syndrome_1 (1 variants)
- Coffin-Siris_syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DPF2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006268.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 41 | 48 | ||||
missense | 12 | 80 | 14 | 115 | ||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
Total | 7 | 13 | 88 | 55 | 7 |
Highest pathogenic variant AF is 6.84053e-7
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DPF2 | protein_coding | protein_coding | ENST00000528416 | 11 | 19496 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000154 | 125260 | 0 | 2 | 125262 | 0.00000798 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.90 | 117 | 245 | 0.478 | 0.0000151 | 2550 |
Missense in Polyphen | 16 | 74.801 | 0.2139 | 729 | ||
Synonymous | -0.243 | 96 | 93.0 | 1.03 | 0.00000541 | 732 |
Loss of Function | 4.86 | 1 | 29.4 | 0.0340 | 0.00000202 | 277 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000886 | 0.00000886 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be a transcription factor required for the apoptosis response following survival factor withdrawal from myeloid cells. Might also have a role in the development and maturation of lymphoid cells.;
- Pathway
- Tumor suppressor activity of SMARCB1;b cell survival pathway;TNFalpha
(Consensus)
Recessive Scores
- pRec
- 0.135
Intolerance Scores
- loftool
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24
Haploinsufficiency Scores
- pHI
- 0.413
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.598
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.935
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Medium |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dpf2
- Phenotype
- renal/urinary system phenotype; limbs/digits/tail phenotype; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- apoptotic process;nervous system development;histone acetylation;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;apoptotic signaling pathway;negative regulation of myeloid progenitor cell differentiation
- Cellular component
- histone acetyltransferase complex;nuclear chromatin;nucleus;nucleoplasm;centrosome;cytosol;intracellular membrane-bounded organelle;nBAF complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;histone acetyltransferase activity;protein binding;histone binding;metal ion binding;H3K9me3 modified histone binding;lysine-acetylated histone binding